少年包青天

《昭和米国物语》IGN首次实机试玩前瞻：复古怪诞B级片世界愤怒循环战斗成核心_我的网站

千图网

一 | CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。 8月26日，IGN发布《昭和米国物语》首次实机试玩前瞻。本作由铃空游戏）开发，自2021年公布以来一直少有更新，本次试玩时长约两小时，由创意总监罗翔宇进行导览，是几年来该作首次较完整对外展示实际游玩内容。游戏预计2026年登陆PC与PS5平台。战斗上，千草蝶子可同时使用徒手/拳套、武士刀、钻头、长柄武器等近战手段，以及霰弹枪、突击步枪等远程武器。近战武器拥有不同招式与“构”（Kamae）切换，例如武士刀可借轻重攻击组合进入“居高”“阴阳”“松风”等架势。核心围绕“愤怒循环（Rage Cycle）”：造成或承受伤害积攒愤怒值并转化为愤怒点（上限5点），用于终结技、愤怒攻击、连锁攻击、完美闪避与超恢复。IGN在试玩中提到，当前版本战斗手感与敌我交互仍显粗糙，命中顿帧偏重、敌人攻击时机较难读判，但多武器切换与愤怒循环的资源管理思路已具雏形。

二 | 养成方面，游戏采用实时升级，升级自动提升生命、耐力、愤怒、防御、近战、射击等核心属性，并授予BP解锁技能。武器具基础威力、愤怒生成、破防、暴击率、暴击倍率、耐力消耗六项属性，可用美元与改造部件升至五级，最多七个增益槽。大本营为一台名为“Guren”的房车，玩家以第一人称视角交流、装饰，并通过行动点（AP）进行泡澡、健身等日常活动，提升属性与八种异常状态抗性。视觉与氛围上，温泉旅馆、新横滨登山段等场景细节与怀旧感获IGN肯定，配乐大量采用昭和风格授权曲目，并收录乡广美《苍茫的卡萨布兰卡》（Aishuu no Casablanca）等歌曲；剧情融合黑暗幽默与中外网络梗，部分过场以类似《如龙》的PPT风格呈现。IGN认为，该作成功塑造出独特的B级片式怪诞世界，但整体打磨度与战斗深度目前仍落后于现代3A动作游戏。